000 | 01641cam a22003977a 4500 | ||
---|---|---|---|
001 | P 1541 | ||
005 | 20140212102809.0 | ||
008 | 070928s2008 njua b 001 0 eng d | ||
010 | _a 2007938391 | ||
015 |
_aGBA769202 _2bnb |
||
016 | 7 |
_a013829429 _2Uk |
|
020 | _a1588298582 (hbk.) | ||
020 | _a9781588298584 (hbk.) | ||
035 | _a(OCoLC)ocn166627310 | ||
040 |
_aUKM _cUKM _dYDXCP _dBTCTA _dBAKER _dNTE _dIXA _dDLC |
||
042 | _alccopycat | ||
050 | 0 | 0 |
_aQP551 _b.C36-2008 |
082 | 0 | 4 |
_a616.99404227 _222 |
245 | 0 | 0 |
_aCancer proteomics : _bfrom bench to bedside / _cedited by Sayed S. Daoud. |
260 |
_aTotowa, N.J. : _bHumana, _cc2008. |
||
300 |
_axii, 264 p. : _bill. (some col.) ; _c24 cm. |
||
440 | 0 | _aCancer drug discovery and development | |
504 | _aIncludes bibliographical references and index. | ||
505 | _aProteomics technologies -- Cell signaling proteomics -- Tumor proteomics -- Bioinformatics and regulatory aspects of proteomics. | ||
650 | 0 |
_aAntineoplastic agents _xDevelopment. |
|
650 | 0 |
_aCancer _xMolecular aspects. |
|
650 | 0 |
_aProteomics _xMethodology. |
|
700 | 1 | _aDaoud, Sayed S. | |
856 | 4 | 1 |
_3Table of contents only _uhttp://www.loc.gov/catdir/enhancements/fy0826/2007938391-t.html |
856 | 4 | 2 |
_3Publisher description _uhttp://www.loc.gov/catdir/enhancements/fy0826/2007938391-d.html |
906 |
_a7 _bcbc _ccopycat _d2 _encip _f20 _gy-gencatlg |
||
925 | 0 |
_aacquire _b2 shelf copies _xpolicy default |
|
942 | _cBK | ||
999 |
_c6604 _d6604 |